The blood dialyzer market size is estimated to reach USD 10.17 billion by 2030, expanding at a CAGR of 6.3% from 2023 to 2030, according to the recent reports of Coherent Market Insights, Inc. Hemodialysis is the most common form of renal replacement therapy used around the world. The study of hemodialysis patients’ requirements has received more attention in recent decades. The failure, unpleasant effects, and unfavorable results of previous dialysis methods are paving the way for increased need for blood dialyzers, which will fuel the market’s expansion over the next few years.
Hemodialyzers, or blood dialyzers, are used to drain the kidneys of excess fluid. Dialyzers work by establishing a pressure difference between their two chambers, allowing for the removal of excess fluid. An arteriovenous fistula (AV), intravenous catheter, or synthetic grafts are the three main ways utilized to access the blood during hemodialysis. Factors like the projected course of a patient’s renal failure and the status of a patient’s vasculature affect the type of access to these procedures.
Request Sample Report + All Related Graphs & Charts:
https://www.coherentmarketinsights.com/insight/request-sample/2503
We have an updated report [Version – 2023] available.
Top Key Players:
★ Baxter International Inc.,
★ Nikkiso Co. Ltd.,
★ B. Braun SE,
★ CVS Health,
★ Nipro Corporation,
★ Diaverum Deutschland GmbH,
★ NxStage Medical Inc.,
★ Fresenius Medical Care AG & Co. KGaA
★ DaVita Healthcare Partners Inc.,Asahi Kasei Medical Co.
★ Ltd,Browndove Healthcare (F) Ltd
★ BAIN MEDICAL EQUIPMENT(GUANGZHOU)CO.,LTD,
★ SB-KAWASUMI LABORATORIES
★ Medtronic,
★ Jihua Medical Apparatus and Instruments Co., Ltd.,,
★ Allmed Medical Care Holdings Limited
★ JMS Medical Co., Ltd.,
The worldwide blood dialyzer market is predicted to expand as a result of the rising adoption of cellulose membrane in blood dialyzers owing to its compatibility.
The worldwide blood dialyzer market is predicted to increase as a result of the rising use of cellulose membrane in blood dialyzers owing to its compatibility. The cellulose triacetate (CTA) dialysis membrane is one of the most biocompatible in cellulosic membranes, according to a report titled Impact of Dialysis Membranes on Clinical Outcomes: From History to Innovation, published by the National Center for Biotechnology Information on January 26, 2022. Cellulose membranes could be made better by chemically concealing the hydroxyl groups, for example by acylation with acetate groups. These modified membranes are constructed from cellulose acetate, cellulose diacetate (CDA), and cellulose triacetate (CTA), which are all named after the number of acetate groups contained in each cellulose unit (CTA). These structural alterations significantly decreased the availability of membrane-surface hydroxyl groups for binding to complement receptor C3b, the key component that initiates complement activation and is responsible for unfavorable consequences.
The global blood dialyzer market is anticipated to expand in the next years as a result of rising product releases by major industry players.
The worldwide blood dialyzer market is predicted to expand as a result of rising product releases by leading industry players. Nipro Medical Company, a healthcare equipment manufacturer, for instance, released their SURDIAL DX Hemodialysis System to the public in the United States on March 29, 2022. The SURDIAL DX hemodialysis system was developed to provide patients and doctors with the best possible dialysis care. Production facility: Japan. SURDIAL DX’s patient-centric design is the result of extensive feedback from medical professionals who helped shape its functionality, efficiency, and ergonomics.
Impact of Coronavirus (COVID-19) Pandemic
Around a hundred nations have reported cases of COVID-19 since the outbreak in December 2019, and on January 30, 2020, the World Health Organization designated the situation a global public health emergency. The abrupt appearance of COVID-19 has stopped all global activity. Hospitals and medical staff all over the world are working harder than ever to combat this pandemic.
Nevertheless, covid-19 was detrimental to the treatment of kidney illness. In Romania, for instance, the COVID-19 pandemic affected renal disease management, impacting vulnerable patients and worsening their results, as reported in the journal of clinical medicine on April 27, 2022. In order to reduce the exposure and danger of infection for patients with CKD (chronic renal disease), the number of admissions to the department dropped.
This means that the global blood dialyzer market has been stunted by the COVID-19 pandemic.
We Offer Customized Report, Click:
https://www.coherentmarketinsights.com/insight/request-customization/2503
Key Developments:
Over the forecast period, the worldwide blood dialyzer market is anticipated to increase as a result of new product launches by major industry participants. For example, on 26th May, 2022, Medtronic plc, a medical device company, and DaVita Inc., a healthcare company, announced their intention to form a novel, independent medical device company focused on kidney care in order to improve the treatment experience for patients and the quality of care they receive. The company’s goal is to increase access to various dialysis treatments for patients, therefore it plans to offer a wide range of kidney care products and solutions, including those that may be used at home.
Over the projected period, the global blood dialyzer market is anticipated to rise on the back of increasing partnerships between leading industry players. In Japan, for instance, medical device and pharmaceutical maker JMS Co. Ltd. and healthcare provider Fresenius Medical Care formed a strategic distribution relationship in September 2021. Fresenius Medical Care’s home dialysis therapies will be made available to Japanese patients through JMS Co. Ltd. distribution under the terms of the agreement. Home dialysis gives patients more freedom to continue working, going to school, or spending time with friends and family because they can receive treatment in the comfort of their own homes rather than having to travel to a clinic.
Lack of skilled specialists and a rise in the likelihood of bacterial infection linked to the blood dialyzer device are factors slowing the expansion of the global blood dialyzer market. Recalls of products for failing to satisfy regulatory criteria are another factor that could slow the industry during the next few years.
Purchasing the Blood Dialyzer Market:
➣ Outlook for the worldwide Blood Dialyzer market in both developed and emerging markets, both now and in the future.
➣ Both the market segment with the largest projected share and the market segment with the highest CAGR throughout the projection period.
➣ Countries and regions anticipated to experience the fastest development throughout the projected period.
➣ The most recent innovations, market shares, and business tactics used by the key market participants.
➣ Study examines emerging market trends as well as the likelihood that various trends will impact expansion.
➣ Analysis also discusses the factors, challenges, and opportunities that will have a significant impact on the global Blood Dialyzer industry.
➣ Research includes a detailed analysis of market statistics as well as historical and current growth conditions in order to provide futuristic growth estimates.
Purchase This Complete Business Report:
https://www.coherentmarketinsights.com/insight/buy-now/2503
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Blood Dialyzer Market Size Analysis from 2023 to 2030
11.6 COVID-19 Outbreak: Blood Dialyzer Industry Impact
Chapter 2 Global Blood Dialyzer Competition by Types, Applications, and Top Regions and Countries
2.1 Global Blood Dialyzer (Volume and Value) by Type
2.3 Global Blood Dialyzer (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Blood Dialyzer Sales, Consumption, Export, Import by Regions (2017-2023)
Chapter 5 North America Blood Dialyzer Market Analysis
Chapter 6 East Asia Blood Dialyzer Market Analysis
Chapter 7 Europe Blood Dialyzer Market Analysis
Chapter 8 South Asia Blood Dialyzer Market Analysis
Chapter 9 Southeast Asia Blood Dialyzer Market Analysis
Chapter 10 Middle East Blood Dialyzer Market Analysis
Chapter 11 Africa Blood Dialyzer Market Analysis
Chapter 12 Oceania Blood Dialyzer Market Analysis
Chapter 13 South America Blood Dialyzer Market Analysis
Chapter 14 Company Profiles and Key Figures in Blood Dialyzer Business
Chapter 15 Global Blood Dialyzer Market Forecast (2023-2030)
Chapter 16 Conclusions
Explore More Related Insights:
Virtual Clinical Trials Market
Medical Device Testing and Certification Market
U.S. Hospital Emergency Department Market
Portable Medical Devices Market
Cervical Spondylosis Treatment Market
Medical Imaging Reagents Market
Medical Device Cleaning Market
Medical Billing Outsourcing Market
Health All-in-one Machine Market
Medical Devices Reimbursement Market
Homecare Self-Monitoring Device Market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame
CA 94010, United States
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
JAPAN: +81-50-5539-1737
INDIA: +91-848-285-0837